Nucleix Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nucleix Demonstrates Potential of its PCR EpiCheck® Assay to Accurately Differentiate Between Small Cell Lung Cancer (SCLC) Subtypes

SAN DIEGO & REHOVOT, Israel, April 04, 2024 Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced data from a pilot study demonstrating the potential of a simple PCR assay based on EpiCheck® technology to accurately differentiate between small cell lung cancer (SCLC) subtypes. The Company is presenting the data in a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, April 5-10

United statesSan diegoJake robisonMathias ehrichUniversity of texas md anderson cancer centerNucleix ltdAmerican association for cancer researchAmerican associationCancer researchAnnual meetingCancer centerEpigenetic targetsPoster numberThe companySmall cell lung cancerCancer treatment

Nucleix Receives Reimbursement for Bladder EpiCheck® in the Netherlands

Nucleix Receives Reimbursement for Bladder EpiCheck® in the Netherlands
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesFred witjesAharona shualiNetwork eur urol oncolDutch healthcare authorityProduct serviceAffairs at nucleixRadboud university nijmegen medical centreNucleix ltdReceives reimbursementBladder epicheckOncological urologistRadboud university nijmegen medicalOncological urologyRadboud university medicalProfessor witjes

Epigenetic Test May Rule Out High-Grade UTUC

Epigenetic Test May Rule Out High-Grade UTUC
renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaAlberto bredaIsrael nucleix ltdAutonoma university of barcelonaNucleix ltdAutonoma university

Non-Invasive Liquid Biopsy Market to Reach $9 47 Billion - Global Market Analysis & Forecasts to 203

Non-Invasive Liquid Biopsy Market to Reach $9 47 Billion - Global Market Analysis & Forecasts to 203
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United statesLaura woodZymo research corporationLonza groupPerkinelmer incHauser groupMerck kgaOrasure technologies incOffice hours callNucleix ltdBio techne corporationReproductive healthE st office hours callOasis diagnostics corporationNorgen biotek corpPredicine inc